Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anticoagulation treatment and prophylactic edoxaban for cerebral sinus venous thrombosis in an adolescent with acute lymphoblastic leukemia.
Koganesawa M, Matsuno R, Sugishita Y, Kaneko R, Kawabata N, Fujita S, Akiyama K, Toyama D, Yamamoto S. Koganesawa M, et al. Among authors: sugishita y. SAGE Open Med Case Rep. 2021 Apr 29;9:2050313X211013225. doi: 10.1177/2050313X211013225. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 34017593 Free PMC article.
Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report.
Fujita S, Matsuno R, Kawabata N, Sugishita Y, Kaneko R, Koganesawa M, Akiyama K, Toyama D, Yamamoto S. Fujita S, et al. Among authors: sugishita y. SAGE Open Med Case Rep. 2021 May 13;9:2050313X211015511. doi: 10.1177/2050313X211015511. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 34035920 Free PMC article.
Successful Treatment of Pediatric Refractory/Relapsed AML with KIR-Ligand-Mismatched Cord Blood Transplant after FLAG-IDA Reinduction Therapy with or without the GO Regimen.
Toyama D, Matsuno R, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Isoyama K, Yamamoto S. Toyama D, et al. Among authors: sugishita y. Case Rep Hematol. 2020 Feb 12;2020:1378056. doi: 10.1155/2020/1378056. eCollection 2020. Case Rep Hematol. 2020. PMID: 32099697 Free PMC article.
Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
Yamamoto S, Toyama D, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Matsuno R, Isoyama K. Yamamoto S, et al. Among authors: sugishita y. Pediatr Transplant. 2018 Nov;22(7):e13269. doi: 10.1111/petr.13269. Epub 2018 Jul 12. Pediatr Transplant. 2018. PMID: 30003636
Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.
Yamamoto S, Matsuno R, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Toyama D, Isoyama K. Yamamoto S, et al. Among authors: sugishita y. Bone Marrow Transplant. 2017 Jul;52(7):1068-1070. doi: 10.1038/bmt.2017.65. Epub 2017 Apr 3. Bone Marrow Transplant. 2017. PMID: 28368378 No abstract available.
Experience using donor human milk: A single-center cohort study in Japan.
Oikawa K, Nakano Y, Miyazawa T, Hasebe Y, Kuwabara H, Terada T, Sugishita Y, Ebata A, Takase M, Ochiai H, Kokaze A, Mizuno K. Oikawa K, et al. Among authors: sugishita y. Pediatr Int. 2022 Jan;64(1):e15071. doi: 10.1111/ped.15071. Pediatr Int. 2022. PMID: 34817880 Free PMC article.
343 results